BJMO - volume 7, issue 5, december 2013
T. Feys MBA, MSc
From September 27th till the first of October, the ECCO – ESMO – ESTRO European Cancer Congress (ECC) again proved to be the premier cancer congress in Europe. Featuring the strongest and most forward-focused scientific programme to date, the 33 tracks at the meeting spanned the entire oncology spectrum and showcased the latest practice-changing developments in oncology. For a complete overview of abstracts presented at ECC2013 we refer to the congress website (eccamsterdam2013.ecco-org.eu) which also features over 1,000 session webcasts from the meeting. This summary will focus on a selection of top studies presented during the meeting.
(BELG J MED ONCOL 2013;7(5):159–63)
Read moreBJMO - volume 7, issue 4, september 2013
T. Feys MBA, MSc
From May 31st till June 4th, Chicago again hosted the annual meeting of the American Society of Clinical Oncology (ASCO). The ASCO Annual Meeting brought together over 25,000 oncology professionals from a broad range of specialties. This summary does not aim at giving a complete overview of the meeting but will briefly touch on twenty key studies presented at the meeting. All abstracts cited in this summary can be consulted in more detail at the ASCO website (am.asco.org).
(BELG J MED ONCOL 2013;7(4):127–32)
Read moreBJMO - volume 7, issue 3, july 2013
I. Joye MD, K. Verhoeven MD, M. Lambrecht MD, PhD
Highlights of the 2nd ESTRO forum, 19th-23rd April 2013, Geneva, Switzerland.
Organised every other year, the European Society for Radiotherapy and Oncology (ESTRO) Forum follows the concept of combining several meetings encompassing the various aspects of the radiation oncology arena: clinical and translational research, brachytherapy, radiation physics, radiation technology and normal tissue effects of radiotherapy. This approach allows clinicians, medical physicists, radiobiologists, radiation technologists and nurses to attend a plethora of symposia, teaching lectures and debates, all directed at fostering interdisciplinarity and encouraging exchange of knowledge and experience between the professionals involved in radiotherapy. In this brief overview we mainly focus on the important clinical findings presented at the conference. All abstracts are freely available at www.estro.org.
(BELG J MED ONCOL 2013;7(3):98–100)
Read moreBJMO - volume 7, issue 2, may 2013
T. Feys MBA, MSc
From the 24th till the 26th of January, San Francisco was the setting for the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2013. The meeting, cosponsored by ASCO, ASTRO and SSO, again focused on multidisciplinary approaches to the prevention, screening, evaluation, and management of gastrointestinal (GI) cancers.
(BELG J MED ONCOL 2013;7(2):57–59)
Read moreBJMO - volume 7, issue 2, may 2013
T. Feys MBA, MSc
The American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2013 held from the 14th – 16th of February, 2013, in Orlando, Florida, focused on multidisciplinary approaches to the prevention, screening, evaluation, and management of genitourinary (GU) cancers.
(BELG J MED ONCOL 2013;7(2):60–62)
Read moreBJMO - volume 7, issue 1, february 2013
T. Feys MBA, MSc, J. De Grève MD, PhD
From December 4th-8th 2012, San Antonio, Texas, was again transformed into the world’s capital in the fight against breast cancer. The 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) was a joint presentation of the Cancer Therapy & Research Center at the University of Texas Health Science Center at San Antonio, the American Association for Cancer Research, and the Baylor College of Medicine. This years’ meeting drew nearly 8,000 participants from over 90 countries and again proved to be the number one breast cancer meeting in the world. This report does not aim to summarise the entire meeting but discusses the key highlights of the meeting.
(BELG J MED ONCOL 2013;7:31–33)
Read moreBJMO - volume 6, issue 6, december 2012
T. Feys MBA, MSc
On the 23rd and 24th of November 2012, the Jules Bordet Institute and the Belgian Society of Medical Oncology (BSMO) hosted the 6th Belgian symposium on the integration of molecular biology advances into oncology clinical practice. The aim of this meeting once more was to translate the major advances made in molecular and biological understanding in cancer into clear messages for daily oncological, clinical practice. Over the two days, a plethora of Belgian and international key opinion leaders discussed the clinical impact of molecular advances in several tumour types. Given the high quality of the different lectures, it was not surprising to see that the meeting again obtained the ESMO label. (BELG J MED ONCOL 2012;6:207–211)
Read more
Top
